10.00AM AEDT THURSDAY 12 NOVEMBER
BIG CHANGES IN A NEW STRATEGY – THE NEW TEAM TO SEE IT THROUGH
This year has been a challenge for so many organisations and people.
At MSI Australia (MSA), we spent this time focused on two core objectives.
- We continue to provide essential abortion care services to people living in Australia, safely and responsibly, and
- Our staff are safe and supported.
We achieved this by increasing access through tele-abortion services and even chartering private planes to make sure women in rural areas had access.
As we approach our 20th year in operation in Australia, we’ve also been talking to our clients, partners and staff about the foundations that make MSA what it is and what the future looks like beyond 2020, so that we continue to provide access and choice to sexual reproductive healthcare, and especially abortion – in every way possible.
Ahead of launching our new strategy before the end of the year, we wanted to share some changes in our team which will help us enact the actions that will make the strategy a reality.
Cate Grindlay, our new Executive Director of Nursing and Clinical Services, comes to us with high level experience in health across private, public and non-for-profit sectors. She brings a mixture of clinical, leadership and advocacy skills, along with her passion for safe client outcomes. Cate spent two years as a midwife with the Kimberley Health Service and learned a great deal about cultural inclusivity; working alongside indigenous women to provide the care and birth practices they wanted.
Ashley Hogarty is our new Executive Director of Finance and Corporate Services and has a track record of driving improved performance through effective business partnering, enhancing organisational processes and introducing innovative systems. Ashley has national and international experience, most recently in the US as Director of Business Planning and Analysis for biopharmaceutical company Bristol Myers Squibb, supporting the development, operations and upcoming commercial launch of new cell therapy treatments.
Jacquie O’Brien, Director of Public Affairs and Policy leaves us this month as part of a rethink of that function after three and a half years, and we thank her for her commitment and skill and wish her well in her new endeavours. We’re recruiting now for the right person to give us a deeper focus in media and communication, which is also critical to the success of our strategy.
Bonney Corbin will formally take the lead on Policy with her commitment, values and experience, reporting directly to me, which is a reflection of how important policy and advocacy is to our new vision.
We’re also excited to let you know that as part of our new direction we’re opening a flagship sexual reproductive hub in Richmond. It’s been delayed as a consequence of the Covid-19 pandemic and we now expect to open in mid 2021.
We look forward to sharing more about the clinic when we launch our strategy. So watch this space.
Media contact Kate Davis, Head of Communications, MSI Australia, 0428 396 391